GLOBAL CRO SUPPORT
Be it early or late phase clinical research, we focus on delivering highest level of data integrity and regulatory conformance across Biopharma, Medical devices and Consumer Health care globally
ExploreEXCEPTIONAL REGULATORY COMPLIANCE
Successfully cleared 32+ USFDA inspections along with numerous other audits by major regulatory authorities worldwide
ExploreCOMMITMENT TO EXCELLENCE:
Trusted partner in accelerating research and development across Biologics, Biosimilars, Bio Betters, and more
ExploreQUALITY ASSURANCE AND QUALITY CONTROL
Rich expertise in delivering QA/QC milestones such as Intra-Vitro Release Testing (IVRT) / Intra-Vitro Performance Testing (IVPT), NG Tube, Inhalers, and BCS Biowaivers
ExploreOur Journey
Milestone
- Inception of Raptim Research, Navi Mumbai
Our Journey
Milestone
- Successfully cleared first 2 USFDA Inspections
Our Journey
Milestone
- Initiated Clinical Trials Services (Phase II-IV)
Our Journey
Milestone
• Crossed 1000 pivotal BE Studies
• Started In-Vitro services
Our Journey
Milestone
• Added 125 beds at Gandhinagar facility
• UK MHRA Inspection
Our Journey
Milestone
- Cleared 3 Unannounced USFDA Inspections
Our Journey
Milestone
• F2F study through Covid pandemic
• Large Clinical Trials of 900+ patients
• Cleared WHO Inspection
Our Journey
Milestone
• Successfully cleared 27th USFDA Inspection
(BE and IVPT)
Our Journey
Milestone
• Successfully cleared 31st USFDA Inspection
(BE, IVPT and Pt BE studies)
• 5 IVPT studies received USFDA approval
• Crossed 3000+ BE Studies
Our Journey
Milestone
• Total capacity reaches 390 Beds
• DCGI Approval for 12 Bed Phase I facility in Mumbai
• DCGI Approval for 38 beds for BA/BE studies
• GCC Approval
2005
2009
2010
2014
2017
2019
2020
2021
2023
2024
Services
A global CRO for end-to-end clinical excellence, committed to delivering cutting-edge and reliable solutions to revolutionize the field of medicine. Discover our full range of accredited services and let us help you achieve your research goals!
BA/BE
- Healthy Subject (Bioequivalence & Bioavailability) Studies, Pharmacokinetics (PK), Pharmacodynamics (PD) studies
- Patient Based PK/PD and Clinical Endpoint (CE) Studies
In-Vitro Studies
- In-vitro Release Rate Test (IVRT) & In-vitro Permeability Test (IVPT)
- In-vitro binding Studies
- BCS Biowaiver Studies
- Inhalers studies
Special Studies
- In Vivo Tape Stripping
- In Vivo Dermal Microdialysis
- Skin Blanching studies
- Skin Irritation and sensitization test
- Glucose clamp Studies
Clinical Trials
- Early Phase Clinical trials
- Patient based PK/PD/CE studies
- Phase II-III Clinical trials
- Phase IV / Post marketing and related studies
Unlock the full potential of your pharmaceutical research with the Raptim Research lab
At Raptim Research Lab, we are committed to propelling your pharmaceutical projects to new heights with our comprehensive bioanalytical method development and validation services. Trusted by industry leaders, our portfolio features over 600 meticulously validated methods, marking us as a frontrunner in bioanalytical solutions.
Why Choose Raptim Research ?
Expertise
Tailored
Solutions
Regulatory Compliance
Explore Our Assay Library
Dive into our extensive library of assays to discover how we can enhance your research efficiency and outcomes. Partner with us to leverage our proven track record and expertise for your success.
Regulatory Inspections
Raptim Insights
Your Source for Clinical Research Insights